Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136(5):E359–E386. https://doi.org/10.1002/ijc.29210 Epub 2014/09/16. PubMed PMID: 25220842
Article
CAS
PubMed
Google Scholar
Adeloye D, David RA, Aderemi AV, Iseolorunkanmi A, Oyedokun A, Iweala EEJ, Omoregbe N, Ayo CK (2016) An estimate of the incidence of prostate cancer in Africa: a systematic review and meta-analysis. Plos One. 11(4):e0153496. https://doi.org/10.1371/journal.pone.0153496
Article
CAS
PubMed
PubMed Central
Google Scholar
Arbyn M, Castellsagué X, de Sanjosé S, Bruni L, Saraiya M, Bray F, Ferlay J (2011) Worldwide burden of cervical cancer in 2008. Ann Oncol. 22(12):2675–2686. https://doi.org/10.1093/annonc/mdr015
Article
CAS
PubMed
Google Scholar
Organization WH. World Health Organization cancer fact sheet. 2009.
Google Scholar
Farmer P, Frenk J, Knaul FM, Shulman LN, Alleyne G, Armstrong L, Atun R, Blayney D, Chen L, Feachem R, Gospodarowicz M, Gralow J, Gupta S, Langer A, Lob-Levyt J, Neal C, Mbewu A, Mired D, Piot P, Reddy KS, Sachs JD, Sarhan M, Seffrin JR (2010) Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet. 376(9747):1186–1193. https://doi.org/10.1016/S0140-6736(10)61152-X
Article
PubMed
Google Scholar
Taitt HE (2018) Global trends and prostate cancer: a review of incidence, detection, and mortality as influenced by race, ethnicity, and geographic location. Am J Men’s Health. 12(6):1807–1823. https://doi.org/10.1177/1557988318798279
Article
Google Scholar
Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C et al (2012) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. lancet. 380(9859):2197–2223. https://doi.org/10.1016/S0140-6736(12)61689-4
Article
PubMed
Google Scholar
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, AlMazroa MA, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Abdulhak AB, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, Burney P, Carapetis J, Chen H, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahodwala N, de Leo D, Degenhardt L, Delossantos A, Denenberg J, Des Jarlais DC, Dharmaratne SD, Dorsey ER, Driscoll T, Duber H, Ebel B, Erwin PJ, Espindola P, Ezzati M, Feigin V, Flaxman AD, Forouzanfar MH, Fowkes FGR, Franklin R, Fransen M, Freeman MK, Gabriel SE, Gakidou E, Gaspari F, Gillum RF, Gonzalez-Medina D, Halasa YA, Haring D, Harrison JE, Havmoeller R, Hay RJ, Hoen B, Hotez PJ, Hoy D, Jacobsen KH, James SL, Jasrasaria R, Jayaraman S, Johns N, Karthikeyan G, Kassebaum N, Keren A, Khoo JP, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Lipnick M, Lipshultz SE, Ohno SL, Mabweijano J, MacIntyre MF, Mallinger L, March L, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGrath J, Memish ZA, Mensah GA, Merriman TR, Michaud C, Miller M, Miller TR, Mock C, Mocumbi AO, Mokdad AA, Moran A, Mulholland K, Nair MN, Naldi L, Narayan KMV, Nasseri K, Norman P, O'Donnell M, Omer SB, Ortblad K, Osborne R, Ozgediz D, Pahari B, Pandian JD, Rivero AP, Padilla RP, Perez-Ruiz F, Perico N, Phillips D, Pierce K, Pope CA III, Porrini E, Pourmalek F, Raju M, Ranganathan D, Rehm JT, Rein DB, Remuzzi G, Rivara FP, Roberts T, de León FR, Rosenfeld LC, Rushton L, Sacco RL, Salomon JA, Sampson U, Sanman E, Schwebel DC, Segui-Gomez M, Shepard DS, Singh D, Singleton J, Sliwa K, Smith E, Steer A, Taylor JA, Thomas B, Tleyjeh IM, Towbin JA, Truelsen T, Undurraga EA, Venketasubramanian N, Vijayakumar L, Vos T, Wagner GR, Wang M, Wang W, Watt K, Weinstock MA, Weintraub R, Wilkinson JD, Woolf AD, Wulf S, Yeh PH, Yip P, Zabetian A, Zheng ZJ, Lopez AD, Murray CJL (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 380(9859):2095–2128. https://doi.org/10.1016/S0140-6736(12)61728-0
Article
PubMed
Google Scholar
Chu LW, Ritchey J, Devesa SS, Quraishi SM, Zhang H, Hsing AW (2011) Prostate cancer incidence rates in Africa. Prostate Cancer 2011:947870. Epub 2011/08/01, PubMed PMID: 22111004. https://doi.org/10.1155/2011/947870
Article
PubMed
PubMed Central
Google Scholar
Egue M, Gnangnon FHR, Akele-Akpo MT, Maxwell PD (2019) Cancer incidence in Cotonou (Benin), 2014-2016: first results from the Cancer Registry of Cotonou. Cancer Epidemiol. 59:46–50. https://doi.org/10.1016/j.canep.2019.01.006 Epub 2019/01/28. PubMed PMID: 30685574
Article
PubMed
Google Scholar
Medhin LB, Achila OO, Syum BE, Gebremichael KH, Said SM, Lobeck H et al (2020) Incidence of prostate cancer in Eritrea: data from the National Health Laboratory, Orotta Referral Hospital and Sembel Hospital 2011-2018. Plos One 15(4):e0232091. https://doi.org/10.1371/journal.pone.0232091 Epub 2020/04/24. PubMed PMID: 32324838; PubMed Central PMCID: PMCPMC7179877
Article
CAS
PubMed
PubMed Central
Google Scholar
Carrilho C, Fontes F, Tulsidás S, Lorenzoni C, Ferro J, Brandão M, Ferro A, Lunet N (2019) Cancer incidence in Mozambique in 2015-2016: data from the Maputo Central Hospital Cancer Registry. Eur J Cancer Prev. 28(4):373–376. https://doi.org/10.1097/cej.0000000000000457 Epub 2018/06/26. PubMed PMID: 29939861
Article
PubMed
Google Scholar
Okongo F, Ogwang DM, Liu B, Maxwell PD (2019) Cancer incidence in Northern Uganda (2013-2016). Int J Cancer. 144(12):2985–2991. https://doi.org/10.1002/ijc.32053 Epub 2018/12/12. PubMed PMID: 30536374
Article
CAS
PubMed
Google Scholar
Koon Sun Pat M, Manraj M, Fauzee J, Sewsurn S, Parkin DM, Manraj S (2019) Trends in cancer incidence in the Republic of Mauritius, 1991–2015. Cancer Epidemiol 63:101616. https://doi.org/10.1016/j.canep.2019.101616
Article
PubMed
Google Scholar
Elidrissi Errahhali M, Elidrissi Errahhali M, Ouarzane M, Boulouiz R, Bellaoui M (2017) Cancer incidence in eastern Morocco: cancer patterns and incidence trends, 2005-2012. BMC Cancer 17(1):587. https://doi.org/10.1186/s12885-017-3597-6 PubMed PMID: 28851324
Article
PubMed
PubMed Central
Google Scholar
Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K (2000) Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343(2):78–85. https://doi.org/10.1056/NEJM200007133430201
Article
CAS
PubMed
Google Scholar
Hjelmborg JB, Scheike T, Holst K, Skytthe A, Penney KL, Graff RE, Pukkala E, Christensen K, Adami HO, Holm NV, Nuttall E, Hansen S, Hartman M, Czene K, Harris JR, Kaprio J, Mucci LA (2014) The heritability of prostate cancer in the Nordic Twin Study of Cancer. Cancer Epidemiol Prev Biomark 23(11):2303–2310. https://doi.org/10.1158/1055-9965.EPI-13-0568
Article
Google Scholar
Verhage BA, Aben KK, Witjes JA, Straatman H, Schalken JA, Kiemeney LA (2004) Site-specific familial aggregation of prostate cancer. Int J Cancer. 109(4):611–617. https://doi.org/10.1002/ijc.20015
Article
CAS
PubMed
Google Scholar
Mucci LA, Hjelmborg JB, Harris JR, Czene K, Havelick DJ, Scheike T, Graff RE, Holst K, Möller S, Unger RH, McIntosh C, Nuttall E, Brandt I, Penney KL, Hartman M, Kraft P, Parmigiani G, Christensen K, Koskenvuo M, Holm NV, Heikkilä K, Pukkala E, Skytthe A, Adami HO, Kaprio J, for the Nordic Twin Study of Cancer (NorTwinCan) Collaboration (2016) Familial risk and heritability of cancer among twins in Nordic countries. JAMA. 315(1):68–76. https://doi.org/10.1001/jama.2015.17703
Article
CAS
PubMed
PubMed Central
Google Scholar
Rebbeck TR (2017) Prostate cancer genetics: variation by race, ethnicity, and geography. Semin Radiat Oncol 27(1):3–10. https://doi.org/10.1016/j.semradonc.2016.08.002
Article
PubMed
Google Scholar
Eeles R, Goh C, Castro E, Bancroft E, Guy M, Al Olama AA et al (2014) The genetic epidemiology of prostate cancer and its clinical implications. Nat Rev Urol. 11(1):18–31. https://doi.org/10.1038/nrurol.2013.266
Article
CAS
PubMed
Google Scholar
Fall B, Ze ondo C, Sarr A, Ouedraogo B, Sow Y, Thiam A et al (2015) Détection précoce du cancer de la prostate chez des apparentés de premier degré au Sénégal. Afr J Urol 21(4):225–229. https://doi.org/10.1016/j.afju.2015.08.002
Article
Google Scholar
Nemesure B, Wu S-Y, Hennis A, Leske MC (2013) Family history of prostate cancer in a black population. J Immigr Minor Health. 15(6):1107–1112. https://doi.org/10.1007/s10903-012-9710-7 PubMed PMID: 22936456
Article
PubMed
Google Scholar
Hayes RB, Liff JM, Pottern LM, Greenberg RS, Schoenberg JB, Schwartz AG, Swanson GM, Silverman DT, Brown LM, Hoover RN, Fralmeni JF Jr (1995) Prostate cancer risk in US blacks and whites with a family history of cancer. Int J Cancer. 60(3):361–364. https://doi.org/10.1002/ijc.2910600315
Article
CAS
PubMed
Google Scholar
Whittemore AS, Wu AH, Kolonel LN, John EM, Gallagher RP, Howe GR, West DW, Teh CZ, Stamey T (1995) Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada. Am J Epidemiol. 141(8):732–740. https://doi.org/10.1093/oxfordjournals.aje.a117495
Article
CAS
PubMed
Google Scholar
Sanderson M, Coker AL, Logan P, Zheng W, Fadden MK (2004) Lifestyle and prostate cancer among older African-American and Caucasian men in South Carolina. Cancer Causes Control. 15(7):647–655. https://doi.org/10.1023/B:CACO.0000036172.63845.d4
Article
PubMed
PubMed Central
Google Scholar
Petersen DC, Jaratlerdsiri W, van Wyk A, Chan EKF, Fernandez P, Lyons RJ et al (2019) African KhoeSan ancestry linked to high-risk prostate cancer. BMC Med Genomics 12(1):82. https://doi.org/10.1186/s12920-019-0537-0 PubMed PMID: 31164124
Article
PubMed
PubMed Central
Google Scholar
Stefflova K, Dulik MC, Barnholtz-Sloan JS, Pai AA, Walker AH, Rebbeck TR (2011) Dissecting the within-Africa ancestry of populations of African descent in the Americas. Plos one. 6(1):e14495. https://doi.org/10.1371/journal.pone.0014495
Article
CAS
PubMed
PubMed Central
Google Scholar
Murphy AB, Ukoli F, Freeman V, Bennett F, Aiken W, Tulloch T, Coard K, Angwafo F, Kittles RA (2012) 8q24 risk alleles in West African and Caribbean men. Prostate. 72(12):1366–1373. https://doi.org/10.1002/pros.22486
Article
CAS
PubMed
PubMed Central
Google Scholar
Haiman CA, Patterson N, Freedman ML, Myers SR, Pike MC, Waliszewska A, Neubauer J, Tandon A, Schirmer C, McDonald GJ, Greenway SC, Stram DO, le Marchand L, Kolonel LN, Frasco M, Wong D, Pooler LC, Ardlie K, Oakley-Girvan I, Whittemore AS, Cooney KA, John EM, Ingles SA, Altshuler D, Henderson BE, Reich D (2007) Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet. 39(5):638–644. https://doi.org/10.1038/ng2015
Article
CAS
PubMed
PubMed Central
Google Scholar
Han Y, Rand KA, Hazelett DJ, Ingles SA, Kittles RA, Strom SS et al (2016) Prostate cancer susceptibility in men of African ancestry at 8q24. J Natl Cancer Inst 108(7). https://doi.org/10.1093/jnci/djv431 Epub 2016/01/30, PubMed PMID: 26823525; PubMed Central PMCID: PMCPMC4948565
Chung CC, Hsing AW, Yeboah E, Biritwum R, Tettey Y, Adjei A, Cook MB, de Marzo A, Netto G, Tay E, Boland JF, Yeager M, Chanock SJ (2014) A comprehensive resequence-analysis of 250 kb region of 8q24. 21 in men of African ancestry. Prostate. 74(6):579–589. https://doi.org/10.1002/pros.22726
Article
CAS
PubMed
PubMed Central
Google Scholar
Du Z, Lubmawa A, Gundell S, Wan P, Nalukenge C, Muwanga P et al (2018) Genetic risk of prostate cancer in Ugandan men. Prostate. 78(5):370–376. https://doi.org/10.1002/pros.23481
Article
CAS
PubMed
PubMed Central
Google Scholar
Fernandez P, Salie M, du Toit D, van der Merwe A (2015) Analysis of prostate cancer susceptibility variants in South African men: replicating associations on chromosomes 8q24 and 10q11. Prostate Cancer. 2015:465184–465186. https://doi.org/10.1155/2015/465184
Article
PubMed
PubMed Central
Google Scholar
Ahmadiyeh N, Pomerantz MM, Grisanzio C, Herman P, Jia L, Almendro V, He HH, Brown M, Liu XS, Davis M, Caswell JL, Beckwith CA, Hills A, MacConaill L, Coetzee GA, Regan MM, Freedman ML (2010) 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC. Proc Natl Acad Sci. 107(21):9742–9746. https://doi.org/10.1073/pnas.0910668107
Article
PubMed
Google Scholar
Pomerantz MM, Beckwith CA, Regan MM, Wyman SK, Petrovics G, Chen Y, Hawksworth DJ, Schumacher FR, Mucci L, Penney KL, Stampfer MJ, Chan JA, Ardlie KG, Fritz BR, Parkin RK, Lin DW, Dyke M, Herman P, Lee S, Oh WK, Kantoff PW, Tewari M, McLeod DG, Srivastava S, Freedman ML (2009) Evaluation of the 8q24 prostate cancer risk locus and MYC expression. Cancer Res. 69(13):5568–5574. https://doi.org/10.1158/0008-5472.CAN-09-0387
Article
CAS
PubMed
PubMed Central
Google Scholar
Cook MB, Wang Z, Yeboah ED, Tettey Y, Biritwum RB, Adjei AA, Tay E, Truelove A, Niwa S, Chung CC, Chokkalingam AP, Chu LW, Yeager M, Hutchinson A, Yu K, Rand KA, Haiman CA, Hoover RN, Hsing AW, Chanock SJ, Consortium AAPCG. A genome-wide association study of prostate cancer in West African men. Hum Genet. 2014;133(5):509–21.
Cook MB, Wang Z, Yeboah ED, Tettey Y, Biritwum RB, Adjei AA et al (2014) A genome-wide association study of prostate cancer in West African men. Human Genet. 133(5):509–521. https://doi.org/10.1007/s00439-013-1387-z
Article
CAS
Google Scholar
Conti DV, Wang K, Sheng X, Bensen JT, Hazelett DJ, Cook MB et al (2017) Two novel susceptibility loci for prostate cancer in men of African ancestry. J Natl Cancer Inst 109(8). https://doi.org/10.1093/jnci/djx084 Epub 2017/11/09. PubMed PMID: 29117387; PubMed Central PMCID: PMCPMC5448553
Akamatsu S, Takata R, Haiman CA, Takahashi A, Inoue T, Kubo M, Furihata M, Kamatani N, Inazawa J, Chen GK, le Marchand L, Kolonel LN, Katoh T, Yamano Y, Yamakado M, Takahashi H, Yamada H, Egawa S, Fujioka T, Henderson BE, Habuchi T, Ogawa O, Nakamura Y, Nakagawa H (2012) Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese. Nat Genet. 44(4):426–429. https://doi.org/10.1038/ng.1104
Article
CAS
PubMed
Google Scholar
Du M, Tillmans L, Gao J, Gao P, Yuan T, Dittmar RL et al (2016) Chromatin interactions and candidate genes at ten prostate cancer risk loci. Sci Rep. 6(1):1–13
Article
Google Scholar
Kote-Jarai Z, Al Olama AA, Giles GG, Severi G, Schleutker J, Weischer M et al (2011) Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet. 43(8):785–791. https://doi.org/10.1038/ng.882
Article
CAS
PubMed
PubMed Central
Google Scholar
Sun J, Zheng SL, Wiklund F, Isaacs SD, Li G, Wiley KE, Kim ST, Zhu Y, Zhang Z, Hsu FC, Turner AR, Stattin P, Liu W, Kim JW, Duggan D, Carpten J, Isaacs W, Grönberg H, Xu J, Chang BL (2009) Sequence variants at 22q13 are associated with prostate cancer risk. Cancer Res. 69(1):10–15. https://doi.org/10.1158/0008-5472.CAN-08-3464 PubMed PMID: 19117981
Article
CAS
PubMed
PubMed Central
Google Scholar
Harlemon M, Ajayi O, Kachambwa P, Kim MS, Simonti CN, Quiver MH, Petersen DC, Mittal A, Fernandez PW, Hsing AW, Baichoo S. A custom genotyping array reveals population-level heterogeneity for the genetic risks of prostate cancer and other cancers in Africa. Cancer research. 2020;80(13):2956–66.
Haiman CA, Chen GK, Blot WJ, Strom SS, Berndt SI, Kittles RA, Rybicki BA, Isaacs WB, Ingles SA, Stanford JL, Diver WR, Witte JS, Hsing AW, Nemesure B, Rebbeck TR, Cooney KA, Xu J, Kibel AS, Hu JJ, John EM, Gueye SM, Watya S, Signorello LB, Hayes RB, Wang Z, Yeboah E, Tettey Y, Cai Q, Kolb S, Ostrander EA, Zeigler-Johnson C, Yamamura Y, Neslund-Dudas C, Haslag-Minoff J, Wu W, Thomas V, Allen GO, Murphy A, Chang BL, Zheng SL, Leske MC, Wu SY, Ray AM, Hennis AJM, Thun MJ, Carpten J, Casey G, Carter EN, Duarte ER, Xia LY, Sheng X, Wan P, Pooler LC, Cheng I, Monroe KR, Schumacher F, le Marchand L, Kolonel LN, Chanock SJ, Berg DVD, Stram DO, Henderson BE (2011) Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nat Genet. 43(6):570–573. https://doi.org/10.1038/ng.839 Epub 2011/05/22, PubMed PMID: 21602798
Article
CAS
PubMed
PubMed Central
Google Scholar
Fernandez P, De Beer P, Van der Merwe L, Heyns C (2010) Genetic variations in androgen metabolism genes and associations with prostate cancer in South African men. South Afr Med J. 100(11):741–745. https://doi.org/10.7196/SAMJ.4104
Article
CAS
Google Scholar
Souiden Y, Mahdouani M, Chaieb K, Elkamel R, Mahdouani K (2011) CYP17 gene polymorphism and prostate cancer susceptibility in a Tunisian population. Cancer epidemiology. 35(5):480–484. https://doi.org/10.1016/j.canep.2010.11.008
Article
CAS
PubMed
Google Scholar
Souiden Y, Mahdouani M, Chaieb K, Bakhrouf A, Mahdouani K (2012) Lack of association of CYP1A1 polymorphism with prostate cancer susceptibility of Tunisian men. Genet Testing Mol Biomark. 16(7):661–666. https://doi.org/10.1089/gtmb.2011.0212
Article
CAS
Google Scholar
Fernandez P, Zeigler-Johnson CM, Spangler E, van der Merwe A, Jalloh M, Gueye SM, Rebbeck TR (2012) Androgen metabolism gene polymorphisms, associations with prostate cancer risk and pathological characteristics: a comparative analysis between South African and Senegalese men. Prostate Cancer. 2012:1–8. https://doi.org/10.1155/2012/798634
Article
CAS
Google Scholar
Taioli E, Sears V, Watson A, Flores-Obando RE, Jackson MD, Ukoli FA, de Syllos Cólus IM, Fernandez P, McFarlane-Anderson N, Ostrander EA, Rodrigues IS, Stanford JL, Taylor JA, Tulloch-Reid M, Ragin CCR (2013) Polymorphisms in CYP17 and CYP3A4 and prostate cancer in men of African descent. Prostate. 73(6):668–676. https://doi.org/10.1002/pros.22612
Article
CAS
PubMed
Google Scholar
Apolonia NV, Lorca AR, Alonso MG, Bahri R, Harich N, Cuenca DS, Esteban ME, Santander AF. Genetic diversity of CYP3A4 and CYP3A5 polymorphisms in North African populations: data from Morocco and Tunisia. London: SAGE Publications Sage UK; 2015.
Brureau L, Moningo D, Emeville E, Ferdinand S, Punga A, Lufuma S, Blanchet P, Romana M, Multigner L (2016) Polymorphisms of estrogen metabolism-related genes and prostate cancer risk in two populations of African ancestry. Plos One. 11(4):e0153609. https://doi.org/10.1371/journal.pone.0153609
Article
CAS
PubMed
PubMed Central
Google Scholar
Fernandez P, de Beer PM, van der Merwe L, Heyns CF (2008) COX-2 promoter polymorphisms and the association with prostate cancer risk in South African men. Carcinogenesis. 29(12):2347–2350. https://doi.org/10.1093/carcin/bgn245
Article
CAS
PubMed
Google Scholar
Fawzy MS, Elfayoumi A-R, Mohamed RH, Fatah IRA, Saadawy SF (2016) Cyclooxygenase 2 (rs2745557) polymorphism and the susceptibility to benign prostate hyperplasia and prostate cancer in Egyptians. Biochem Genet. 54(3):326–336. https://doi.org/10.1007/s10528-016-9722-4
Article
CAS
PubMed
Google Scholar
Souiden Y, Mahdouani M, Chaieb K, Elkamel R, Mahdouani K (2010) Polymorphisms of glutathione-S-transferase M1 and T1 and prostate cancer risk in a Tunisian population. Cancer Epidemiol. 34(5):598–603. https://doi.org/10.1016/j.canep.2010.06.002
Article
CAS
PubMed
Google Scholar
Benabdelkrim M, Djeffal O, Berredjem H (2018) GSTM1 and GSTT1 polymorphisms and susceptibility to prostate cancer: a case-control study of the Algerian population. Asian Pac J Cancer Prev 19(10):2853–2858. https://doi.org/10.22034/APJCP.2018.19.10.2853
Article
CAS
PubMed
PubMed Central
Google Scholar
Said R, Bougatef K, Boubaker NS, Jenni R, Derouiche A, Chebil M et al (2019) Polymorphisms in XPC gene and risk for prostate cancer. Mol Biol Rep. 46(1):1117–1125. https://doi.org/10.1007/s11033-018-4572-2
Article
CAS
PubMed
Google Scholar
Djomkam ALZ, Beyeme Sala T, Baari Memba C, Njimoh DL (2019) Prevalence of the Ser217Leu variant of the ELAC2 gene and its association with prostate cancer in population of the Littoral region of Cameroon. Prostate Cancer. 2019:1–6. https://doi.org/10.1155/2019/5974928
Article
CAS
Google Scholar
Akinloye O, Gromoll J, Simoni M (2011) Variation in CAG and GGN repeat lengths and CAG/GGN haplotype in androgen receptor gene polymorphism and prostate carcinoma in Nigerians. Br J Biom Sci. 68(3):138–142. https://doi.org/10.1080/09674845.2011.11730341
Article
CAS
Google Scholar
Sfar S, Saad H, Mosbah F, Chouchane L (2008) Association of HSP70-hom genetic variant with prostate cancer risk. Mol Biol Rep. 35(3):459–464. https://doi.org/10.1007/s11033-007-9107-1
Article
CAS
PubMed
Google Scholar
de Vries J, Munung SN, Matimba A, McCurdy S, Oukem-Boyer OOM, Staunton C et al (2017) Regulation of genomic and biobanking research in Africa: a content analysis of ethics guidelines, policies and procedures from 22 African countries. BMC Med Ethics. 18(1):1–9
Article
Google Scholar
Ayuku S (2017) Establishing a Cancer Research Consortium in low-and middle-income countries: challenges faced and lessons learned
Google Scholar
Zhang Q (2015) Associating rare genetic variants with human diseases. Front Genet. 6:133
Article
Google Scholar
Wu X, Gu J (2016) Heritability of prostate cancer: a tale of rare variants and common single nucleotide polymorphisms. Ann Transl Med 4:206. https://doi.org/10.21037/atm.2016.05.31
Article
CAS
PubMed
PubMed Central
Google Scholar